Open Access
CC BY-NC-ND 4.0 · Sleep Sci 2024; 17(04): e470-e475
DOI: 10.1055/s-0044-1782176
Overview Article

Circadian Pattern in Restless Legs Syndrome: Implications for Treatment Posology

1   Neurology Department, Centro Integral de Sueño y Neurociencias (CISNe), Madrid, Spain
,
Irene Cano-Pumarega
1   Neurology Department, Centro Integral de Sueño y Neurociencias (CISNe), Madrid, Spain
2   Respiratory Department, Sleep Unit, Hospital Ramón y Cajal (IRYCIS), Madrid, Spain
3   Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Madrid, Spain
,
Andrea Castro-Villacañas-Farzamnia
1   Neurology Department, Centro Integral de Sueño y Neurociencias (CISNe), Madrid, Spain
,
Sara Boi
1   Neurology Department, Centro Integral de Sueño y Neurociencias (CISNe), Madrid, Spain
› Institutsangaben

Funding Source The authors declare that they have received no funding from agencies in the public, private or non-profit sectors for the conduction of the present study.
Preview

Abstract

The symptoms of restless legs syndrome (RLS) follow a circadian pattern, as inducated in the current RLS diagnostic criteria. Indeed, subjects with mild-to-moderate RLS suffer or not from RLS symptoms depending on the time of day, resembling an above-threshold state periodically followed by a below-threshold state. Although the circadian clock is crucial in the clinical features of RLS, research assessing the ultimate drivers of circadian rhythmicity is still very limited. In the present review, we show current evidence on circadian variations of neurotransmitters involved in the pathophysiology of RLS (systemic iron metabolism, brain iron homeostasis, adenosine, dopamine, glutamate, and endogenous opioids). Secondly, an overview of available therapies for RLS is presented, including information on current recommendations for symptomatic treatments in RLS.

We discuss the importance of further research into the circadian oscillations that occur in RLS, so that they can be managed, and a protective below-threshold state can be established on an individualized basis. In addition, we also discuss the current dosing of the medications prescribed in RLS symptomatic treatments, and how circadian factors should be considered to better adjust dosing on an individualized basis and increase the therapeutic benefit.



Publikationsverlauf

Eingereicht: 15. Mai 2023

Angenommen: 16. November 2023

Artikel online veröffentlicht:
09. April 2024

© 2024. Brazilian Sleep Association. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil